Faculty Opinions recommendation of Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.

Combined Chemotherapy ◽

Oncology Group ◽

Pelvic Radiotherapy ◽

Phase Iii Trial ◽

Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.09.029 ◽

2008 ◽

Vol 108 (1) ◽

pp. 226-233 ◽

Cited By ~ 301

Author(s):

Nobuyuki Susumu ◽

Satoru Sagae ◽

Yasuhiro Udagawa ◽

Kenji Niwa ◽

Hiroyuki Kuramoto ◽

...

Keyword(s):

Endometrial Cancer ◽

High Risk ◽

Gynecologic Oncology ◽

Phase Iii ◽

Combined Chemotherapy ◽

Oncology Group ◽

Pelvic Radiotherapy ◽

Phase Iii Trial ◽

920 POSTER A randomized phase III trial of pelvic radiotherapy versus cisplatinbased combined chemotherapy in patients with intermediate risk endometrial carcinoma: a Japan gynecologic oncology group study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81215-7 ◽

2005 ◽

Vol 3 (2) ◽

pp. 265

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Intermediate Risk ◽

Combined Chemotherapy ◽

Oncology Group ◽

Pelvic Radiotherapy ◽

Phase Iii Trial ◽

Faculty Opinions recommendation of Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8972962.9534062 ◽

2011 ◽

Author(s):

Lee-May Chen

Keyword(s):

Gynecologic Oncology ◽

Low Risk ◽

Phase Iii ◽

Gestational Trophoblastic Neoplasia ◽

Oncology Group ◽

Phase Iii Trial ◽

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.11.013 ◽

2006 ◽

Vol 100 (1) ◽

pp. 27-32 ◽

Cited By ~ 227

Author(s):

Joan L. Walker ◽

Deborah K. Armstrong ◽

Helen Q. Huang ◽

Jeffrey Fowler ◽

Kenneth Webster ◽

...

Keyword(s):

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Response to Dr. Markman's letter “Re: ‘Randomized phase III trial of three versus six cycles of carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study’”

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.01.007 ◽

2007 ◽

Vol 105 (1) ◽

pp. 280-281

Author(s):

J BELL

Keyword(s):

Ovarian Carcinoma ◽

Early Stage ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

The Women s Oncology Review ◽

10.3109/14733400412331312594 ◽

2004 ◽

Vol 4 (3) ◽

pp. 205-207

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.11.014 ◽

2009 ◽

Vol 112 (3) ◽

pp. 543-552 ◽

Cited By ~ 139

Author(s):

Howard D. Homesley ◽

Virginia Filiaci ◽

Susan K. Gibbons ◽

Harry J. Long ◽

David Cella ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.09.015 ◽

2009 ◽

Vol 112 (1) ◽

pp. 134-141 ◽

Cited By ~ 3

Author(s):

D. Scott McMeekin ◽

Joan L. Walker ◽

Ellen M. Hartenbach ◽

Michael A. Bookman ◽

Wui-Jin Koh

Keyword(s):

Radiation Therapy ◽

Endometrial Cancer ◽

High Risk ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Oncology Group ◽

EP646 Could the long-term oncological safety of laparoscopic surgery in low risk endometrial cancer be also valid for the high intermediate and high-risk patients? A multi-center turkish gynecologic oncology group study conducted with 2745 endometrial cancer cases

10.1136/ijgc-2019-esgo.702 ◽

2019 ◽

Author(s):

MA Vardar ◽

AB Guzel ◽

S Taşkın ◽

M Güngör ◽

N Özgül ◽

...

Keyword(s):

Endometrial Cancer ◽

Laparoscopic Surgery ◽

High Risk ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Oncological Safety ◽

Risk Patients

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70097-6 ◽

2006 ◽

Vol 2006 ◽

pp. 135-137

Author(s):

J.T. Thigpen

Keyword(s):

Uterine Cervix ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽